Latest Breaking News On - Patients with her2 negative metastatic breast cancer - Page 1 : comparemela.com

Yara Abdou, MD, discusses findings from the phase 2 MAINTAIN trial in patients with HER2-negative metastatic breast cancer, as well as the clinical implications of these trial results.

Yara abdouDepartment of medicineUniversity of north carolina school medicineDivision of oncologyNorth carolina schoolMaintain trialPatients with her2 negative metastatic breast cancer